TRDA vs. ARDX

Last updated Apr 1, 2026

Compare and contrast key facts about Entrada Therapeutics, Inc. (TRDA) and Ardelyx, Inc. (ARDX).

Performance

TRDA vs. ARDX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Entrada Therapeutics, Inc. (TRDA) and Ardelyx, Inc. (ARDX). The values are adjusted to include any dividend payments, if applicable.

TRDA vs. ARDX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
TRDA Entrada Therapeutics, Inc.	22.76%	-40.54%	14.58%	11.61%	-21.03%	-28.52%
ARDX Ardelyx, Inc.	4.80%	14.99%	-18.23%	117.54%	159.09%	-9.09%

Fundamentals

Market Cap TRDA : $522.11M ARDX : $1.49B
EPS TRDA : -$3.47 ARDX : -$0.25
PS Ratio TRDA : 20.55 ARDX : 3.63
PB Ratio TRDA : 1.71 ARDX : 8.92
Total Revenue (TTM) TRDA : $25.42M ARDX : $407.32M
Gross Profit (TTM) TRDA : -$14.24M ARDX : $367.78M
EBITDA (TTM) TRDA : -$151.12M ARDX : -$33.44M

Returns By Period

In the year-to-date period, TRDA achieves a 22.76% return, which is significantly higher than ARDX's 4.80% return.

TRDA

• 1D: 7.22%
• 1M: 5.78%
• YTD: 22.76%
• 6M: 117.59%
• 1Y: 39.60%
• 3Y*: -4.52%
• 5Y*: —
• 10Y*: —

ARDX

• 1D: 2.00%
• 1M: -5.56%
• YTD: 4.80%
• 6M: 13.99%
• 1Y: 27.56%
• 3Y*: 8.45%
• 5Y*: -2.29%
• 10Y*: -2.39%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

TRDA vs. ARDX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TRDA

TRDA Risk / Return Rank: 59
TRDA Sharpe Ratio Rank: 64
TRDA Sortino Ratio Rank: 61
TRDA Omega Ratio Rank: 59
TRDA Calmar Ratio Rank: 57
TRDA Martin Ratio Rank: 55

ARDX

ARDX Risk / Return Rank: 56
ARDX Sharpe Ratio Rank: 55
ARDX Sortino Ratio Rank: 57
ARDX Omega Ratio Rank: 57
ARDX Calmar Ratio Rank: 54
ARDX Martin Ratio Rank: 54

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TRDA vs. ARDX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Entrada Therapeutics, Inc. (TRDA) and Ardelyx, Inc. (ARDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TRDA	ARDX	Difference
Sharpe ratio Return per unit of total volatility	0.63	0.40	+0.24
Sortino ratio Return per unit of downside risk	1.25	1.09	+0.16
Omega ratio Gain probability vs. loss probability	1.15	1.15	0.00
Calmar ratio Return relative to maximum drawdown	0.70	0.60	+0.10
Martin ratio Return relative to average drawdown	1.39	1.25	+0.14
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TRDA vs. ARDX - Sharpe Ratio Comparison

The current TRDA Sharpe Ratio is 0.63, which is higher than the ARDX Sharpe Ratio of 0.40. The chart below compares the historical Sharpe Ratios of TRDA and ARDX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	TRDA	ARDX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.63	0.40	+0.24
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.03	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.03	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.16	-0.08	-0.08

Correlation

The correlation between TRDA and ARDX is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

TRDA vs. ARDX - Dividend Comparison

Neither TRDA nor ARDX has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

TRDA vs. ARDX - Drawdown Comparison

The maximum TRDA drawdown since its inception was -85.66%, smaller than the maximum ARDX drawdown of -98.45%. Use the drawdown chart below to compare losses from any high point for TRDA and ARDX.

Drawdown Indicators

	TRDA	ARDX	Difference
Max Drawdown Largest peak-to-trough decline	-85.66%	-98.45%	+12.79%
Max Drawdown (1Y) Largest decline over 1 year	-45.61%	-40.42%	-5.19%
Max Drawdown (5Y) Largest decline over 5 years	—	-94.32%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-96.82%	—
Current Drawdown Current decline from peak	-63.94%	-81.42%	+17.48%
Average Drawdown Average peak-to-trough decline	-62.42%	-77.32%	+14.90%
Ulcer Index Depth and duration of drawdowns from previous peaks	22.98%	19.48%	+3.50%

Volatility

TRDA vs. ARDX - Volatility Comparison

Entrada Therapeutics, Inc. (TRDA) has a higher volatility of 19.07% compared to Ardelyx, Inc. (ARDX) at 16.78%. This indicates that TRDA's price experiences larger fluctuations and is considered to be riskier than ARDX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TRDA	ARDX	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.07%	16.78%	+2.29%
Volatility (6M) Calculated over the trailing 6-month period	43.15%	50.11%	-6.96%
Volatility (1Y) Calculated over the trailing 1-year period	63.09%	69.87%	-6.78%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	86.71%	89.97%	-3.26%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	86.71%	84.26%	+2.45%

Financials